Shannon Weiman earned her PhD in Biomedical Sciences from the University of California, San Diego, specializing in microbiology and immunology. Prior to joining the Keystone Symposia team, she worked as a freelance writer for leaders in academic, industry and government research, including Stanford University’s Biomedical Innovation Initiative, the University of Colorado’s Biofrontiers Program, UCSF, the FDA and the American Society for Microbiology.
The upcoming Keystone Symposia, “Progress in Vaccine Development for Infectious Diseases,” will...
On June 12-16, 2022, Keystone Symposia will host joint meetings on Resolution of Inflammation and...
Nanoparticles are emerging as a powerful mode of delivery for drugs, vaccines and even gene...
Now you can access the latest scientific discoveries and directions from the comfort of your own...
On April 21, 2022, Keystone Symposia will be hosting a free ePanel event to celebrate the inaugural...
As the impacts of climate change are becoming increasingly severe worldwide, Keystone Symposia and...
On Earth Day, 2022, we launched our Climate Health ePanel series in collaboration with the... |
Keystone Symposia was founded on the idea of bringing academic and industry scientists together to...
The convergence of new technology platforms (including induced pluripotent stem cells, CRISPR-Cas9...
This multidisciplinary conference will integrate emerging technologies and immunobiology to advance...
